Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.48
-0.12 (-0.77%)
At close: Nov 13, 2026, 4:00 PM EST
15.20
-0.28 (-1.81%)
After-hours: Nov 13, 2026, 7:45 PM EST
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.69 billion as of November 13, 2026. It is the 7,265th most valuable company in the world and the 1,860th biggest in the United States. Its market cap has increased by 37.09% in one year.
Market Cap
1.69B
Enterprise Value
708.26M
1-Year Change
37.09%
Global Rank
Country Rank
#1,860 United States
Category
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.69B, an increase of 140.19%. That is a compound annual growth rate of 14.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.69B | -12.05% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.74B |
| Sarepta Therapeutics | 1.73B |
| Mesoblast | 1.72B |
| Kailera Therapeutics | 1.72B |
| uniQure | 1.70B |
| Vir Biotechnology | 1.69B |
| Precigen | 1.64B |
| SELLAS Life Sciences Group | 1.64B |